Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Clinical Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Movassaghi, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Movassaghi, N.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Chickenpox
*Shingles
Hazardous Substances DB
*CYTARABINE
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The Prevention and Treatment of Varicella- Zoster Infection in Patients at High Risk

Nasser Movassaghi

Division of Hematology, Children's Hospital of the District of Columbia, and Department of Child Health and Development, George Washington University

Disseminated herpes zoster or varicella can be life-threatening to patients with malignancy or immune deficiency and those receiving immunosuppres sive or cytotoxic drugs. For prevention of the infection, convalescent zoster plasma or Zoster Immune Globulin (ZIG) should be given within 72 hours after exposure to herpes zoster or varicella. For such patients already ill with herpes zoster infection or varicella, cytosine arabinoside should be infused continuously for several days until the infection is under control.

Clinical Pediatrics, Vol. 12, No. 5, 299-301 (1973)
DOI: 10.1177/000992287301200514
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 ANN INTERN MEDHome page
R. DOLIN, R. C. REICHMAN, M. H. MAZUR, and R. J. WHITLEY
Herpes Zoster-Varicella Infections in Immunosuppressed Patients
Ann Intern Med, September 1, 1978; 89(3): 375 - 388.
[Abstract] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
H. H. Balfour Jr, K. E. Groth, J. McCullough, J. M. Kalis, S. C. Marker, M. E. Nesbit, R. L. Simmons, and J. S. Najarian
Prevention or Modification of Varicella Using Zoster Immune Plasma
Arch Pediatr Adolesc Med, June 1, 1977; 131(6): 693 - 696.
[Abstract] [PDF]

Home page
 Arch DermatolHome page
M. Baron and H. L. Wechsler
Low-Dosage Cytarabine Therapy for Herpes Zoster With Pneumonia
Arch Dermatol, July 1, 1975; 111(7): 910 - 912.
[Abstract] [PDF]